Sensus Healthcare, Inc. cash flow statement
In fiscal 2025, Sensus Healthcare, Inc.'s operations generated $528,000 of cash; it spent $196,000 on capital projects, leaving free cash flow of $332,000. It returned $300,000 through buybacks.
Cash flow statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −1 | −1 | −3 | −9 | −2 | −0 | −0 | −1 | −2 | −1 | 1 | −7 |
| Depreciation and amortisation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital spending | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −2 | −1 | −3 | −9 | −3 | −1 | −0 | −2 | −2 | −1 | 0 | −7 |
| Free cash flow after stock pay | −2 | −2 | −4 | −10 | −3 | −1 | −1 | −2 | −3 | −1 | 0 | −7 |
| Share buybacks | — | — | — | — | — | — | — | 3 | 0 | — | 0 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3,953 | −827 | −2,677 | 3,117 | 2,295 | −2,207 | −3,753 | −3,133 |
| Depreciation and amortisation | 53 | 46 | 86 | 99 | 98 | 117 | 96 | 86 |
| Stock-based pay | 0 | 122 | 79 | 5 | 0 | 76 | 70 | 70 |
| Capital spending | 337 | −297 | 7 | 27 | 4 | 158 | 3 | 8 |
| Free cash flow | 3,616 | −530 | −2,684 | 3,090 | 2,291 | −2,365 | −3,756 | −3,141 |
| Free cash flow after stock pay | 3,616 | −652 | −2,763 | 3,085 | 2,291 | −2,441 | −3,826 | −3,211 |
Compare with peers
- Hyperfine, Inc. cash flow
- Spectral AI, Inc. cash flow
- Jin Medical International Ltd. cash flow
- Nephros Inc cash flow
- Vivos Therapeutics, Inc. cash flow
Head to head: HYPR vs SRTSMDAI vs SRTSSRTS vs ZJYL
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies